Παρακολούθηση
Giulia Cheloni
Giulia Cheloni
Beth Israel Deaconess Medical Center, Harvard Medical School
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα bidmc.harvard.edu
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Intragenic antagonistic roles of protein and circRNA in tumorigenesis
J Guarnerio, Y Zhang, G Cheloni, R Panella, J Mae Katon, M Simpson, ...
Cell research 29 (8), 628-640, 2019
1332019
Chronic myelogenous leukemia–initiating cells require Polycomb group protein EZH2
H Xie, C Peng, J Huang, BE Li, W Kim, EC Smith, Y Fujiwara, J Qi, ...
Cancer discovery 6 (11), 1237-1247, 2016
892016
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine
G Cheloni, M Tanturli, I Tusa, N Ho DeSouza, Y Shan, A Gozzini, ...
Blood, The Journal of the American Society of Hematology 130 (5), 655-665, 2017
732017
Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survival
Y Chen, C Peng, SA Abraham, Y Shan, Z Guo, N Desouza, G Cheloni, ...
The Journal of clinical investigation 124 (9), 3847-3862, 2014
622014
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy
E Rovida, S Peppicelli, S Bono, F Bianchini, I Tusa, G Cheloni, I Marzi, ...
Cell Cycle 13 (20), 3169-3175, 2014
512014
Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy
V Mugoni, R Panella, G Cheloni, M Chen, O Pozdnyakova, D Stroopinsky, ...
Cell research 29 (6), 446-459, 2019
402019
Time-and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells
V Barbetti, A Gozzini, G Cheloni, I Marzi, E Fabiani, V Santini, ...
Epigenetics 8 (2), 210-219, 2013
352013
The leukemic stem cell niche: adaptation to “Hypoxia” versus Oncogene Addiction
G Cheloni, M Poteti, S Bono, E Masala, NM Mazure, E Rovida, M Lulli, ...
Stem Cells International 2017, 2017
232017
Targeting the extracellular signal-regulated kinase 5 pathway to suppress human chronic myeloid leukemia stem cells
I Tusa, G Cheloni, M Poteti, A Gozzini, NH DeSouza, Y Shan, X Deng, ...
Stem Cell Reports 11 (4), 929-943, 2018
222018
Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T-cell responses in a murine acute myeloid leukemia model
D Stroopinsky, J Liegel, M Bhasin, G Cheloni, B Thomas, S Bhasin, ...
Haematologica 106 (5), 1330, 2021
202021
Salarin C inhibits the maintenance of chronic myeloid leukemia progenitor cells
E Del Poggetto, M Tanturli, N Ben-Califa, A Gozzini, I Tusa, G Cheloni, ...
Cell Cycle 14 (19), 3146-3154, 2015
132015
Dual DNA and protein tagging of open chromatin unveils dynamics of epigenomic landscapes in leukemia
JD Lee, JA Paulo, RR Posey, V Mugoni, NR Kong, G Cheloni, YR Lee, ...
Nature methods 18 (3), 293-302, 2021
92021
In Vitro comparison of the effects of imatinib and ponatinib on chronic myeloid leukemia progenitor/stem cell features
I Tusa, G Cheloni, M Poteti, A Silvano, A Tubita, Z Lombardi, A Gozzini, ...
Targeted Oncology 15 (5), 659-671, 2020
72020
The culture repopulation ability (CRA) assay and incubation in low oxygen to test antileukemic drugs on imatinib-resistant CML stem-like cells
G Cheloni, M Tanturli
Chronic Myeloid Leukemia: Methods and Protocols, 73-85, 2016
72016
Glutamine availability controls BCR/Abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem/progenitor cell potential
M Poteti, G Menegazzi, S Peppicelli, I Tusa, G Cheloni, A Silvano, ...
Cancers 13 (17), 4372, 2021
42021
Tissue “hypoxia” and the maintenance of leukemia stem cells
P Dello Sbarba, G Cheloni
Leukemia Stem Cells in Hematologic Malignancies, 129-145, 2019
42019
Author Correction: Intragenic antagonistic roles of protein and circRNA in tumorigenesis
J Guarnerio, Y Zhang, G Cheloni, R Panella, JM Katon, M Simpson, ...
Cell Research 30 (2), 188-188, 2020
12020
Targeting Chronic Myeloid Leukemia Stem Cells through Pharmacological Inhibition of HIF-1α
G Cheloni, M Tanturli, DSH Ngoc, Y Shan, I Tusa, E Rovida, S Li, ...
Blood 128 (22), 4235, 2016
12016
Correction to Barbetti V, et al. Epigenetics Volume 8, Issue 2; pp. 210–9
V Barbetti, A Gozzini, G Cheloni, I Marzi, E Fabiani, V Santini, ...
Epigenetics 8 (12), 1384-1384, 2013
2013
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–19